Go to deals
Consumer & Retail | Healthcare | Private Equity

C.B. Fleet Company, Inc. has been acquired by Gryphon Investors

The shareholders of C.B. Fleet Company, Inc. (Fleet Laboratories), the market leader in the personal healthcare and over-the-counter industry, have sold the company to Gryphon Investors, a San Francisco-based middle-market private equity firm. Financial terms have not been disclosed.

Fleet Laboratories, headquartered in Lynchburg, VA and family-owned since its founding in 1869, is a market leader in the personal healthcare and over-the-counter “OTC” industry with such well-known product lines as Summer’s Eve®, FLEET®, Norforms®, Pedia-Lax®, Phazyme®, and Boudreaux’s®. The company has a presence in North America, Asia Pacific and Latin America.

Founded in 1995, Gryphon Investors focuses on leveraged acquisitions of, and growth investments in, middle-market companies in partnership with experienced management teams. With more than US$1.4 billion of cumulative equity commitments, Gryphon has an extensive track record of investing up to US$100 million of its committed capital per investment in companies with sales ranging from approximately US$100 to 500 million.

Dennis O’Brien, a partner at Gryphon, said, “Fleet Laboratories has a commanding position in the OTC and personal healthcare product areas, which we have closely followed for several years. We believe the OTC sector is poised for continued expansion as consumers migrate toward more economical non- prescription products and that Fleet has unique and differentiated capabilities to serve these markets. Additionally, the Company’s strong brand advantage in the personal healthcare segment under the leading feminine hygiene brand, Summer’s Eve, is a springboard for strong future growth.”

As part of the transaction, Steve LaMonte, a Gryphon advisor and an accomplished senior executive in both OTC and personal healthcare businesses who has held leadership positions at Johnson & Johnson, Pfizer, and Schering-Plough, will become Chairman of the Board. CEO Jeff Rowan and the existing management team will remain with the company. Mr. Rowan noted, “We are pleased to be able to leverage Gryphon’s expertise and financial resources as Fleet Laboratories transitions from a family-owned company and continues its long history as a strong competitor in the large and competitive global personal healthcare and OTC markets.”

One of Oaklins' teams in the USA served as the exclusive financial advisor to the seller. This is the fourth transaction our team has completed for Fleet Laboratories.

Service
M&A sell-side
Parties

Talk to the deal team

 W. Gregory  Robertson

W. Gregory Robertson

Managing Director

New York, United States
Oaklins TM Capital
 Paul R. Smolevitz

Paul R. Smolevitz

Managing Director

New York, United States
Oaklins TM Capital

Related deals

Permali Gloucester has been acquired by Diamorph (subject to regulatory approval)
Private Equity | Aerospace & Defense | Automotive | Industrial Machinery & Components

Permali Gloucester has been acquired by Diamorph (subject to regulatory approval)

Private equity firm 3i Group and the private shareholders of Permali Gloucester Limited have sold their interest in the company to Diamorph.

Learn more
BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher
Private Equity | Other Industries

BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher

BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.

Learn more
VækstPartner Kapital and founders and management sell CIM Industrial Systems to XANO
Private Equity | TMT

VækstPartner Kapital and founders and management sell CIM Industrial Systems to XANO

VækstPartner Kapital and the founders and management of the leading pharma/industry 4.0 production software specialist CIM Industrial Systems A/S have sold the company to the listed Swedish group XANO Industri AB.

Learn more